Evidenze Group

What Evidenze Group does

Evidenze Group is a privately-held European Contract Research Organization (CRO) headquartered in Barcelona, Spain, founded in 2020 to provide integrated clinical research and healthcare value-added services across the continent. The company positions itself as a "Full Value CRO" — combining traditional CRO capabilities (study start-up, clinical operations, data management, biostatistics, medical writing, pharmacovigilance, regulatory affairs, and QA audits) with adjacent service lines spanning digital health, patient support programs, scientific communications, and market access/HEOR. It serves approximately 270 clients including biotechs, small and mid-sized pharma, MedTech companies, public health administrations, and large pharmaceutical firms (Bayer, Amgen, Sobi, Otsuka) across direct operations in Spain, Germany, Italy, and Portugal and a partner network extending into 11 additional European countries.

The company operates a platform-plus-modules architecture underpinned by proprietary electronic clinical trial technology — eCRF, ePRO, eConsent, eDiary, eTMF/eISF, eRND, and IWRS — and a series of AI-driven platforms targeting specific therapeutic areas (Hugo 2.0 for Multiple Sclerosis real-world evidence, RaDiPaEm for rare disease AI diagnosis, Cherries for MS wearable monitoring, AlexIA for social-healthcare coordination, and Hemodinn for home hemodialysis). A Biostatistics & Data Science Hub in Essen, Germany employs more than 60 specialists (30% PhD, 60% MSc) supporting CDISC SDTM/ADaM-compliant statistical programming, R Shiny dashboards, and automated reporting pipelines. Quality and regulatory posture is anchored by ISO 9001:2015 (clinical research and patient support programs), ISO 27001, the Spanish National Security Framework (ENS) certification, GDPR compliance, EcoVadis Platinum, and SBTi-approved net-zero targets.

Revenue is generated predominantly through project-based and Functional Service Provision (FSP) contracts with pharmaceutical and biotech sponsors, supplemented by public procurement of innovation (PPI/PCP) engagements with European health authorities and grant funding from EU programs (Horizon 2020, Horizon Europe/Eurostars-3, NextGeneration EU). Pricing is bespoke and not publicly disclosed. In May 2026, Columna Capital acquired a majority stake from Buenavista Equity Partners, with co-founders Pedro Hernández (Vice President) and Albert Gallart retaining a significant minority stake; the company reported €40 million in net revenue for 2025, supported by 400–450 employees.

Name

Evidenze Group

Legal name

EVIDENZE GROUP EUROPE, S.L.

Website

https://evidenze.com

Company type

Private

Founded year

2020

Operating status

Operating

Headcount range

251–500 employees

Short description

Evidenze Group is a Barcelona-based full-value CRO founded in 2020 delivering clinical research, biostatistics, digital health, patient support, scientific communication, and market access services to biotechs, pharma, MedTech, and public health systems across 14+ European countries via proprietary eClinical and AI-enabled real-world evidence tools.

Ownership category

akta.pro rank

Product category

Contract Research Organization (CRO) Services

NAICS

Scientific Research and Development Services (5417), Other Scientific and Technical Consulting Services (541690), Research and Development in Biotechnology (except Nanobiotechnology) (541714)

SIC

Services-Commercial Physical & Biological Research (8731)

akta.pro primary industry

Clinical CROs (Phase I–IV) (HLAGAAAA)

akta.pro secondary industries

Real-World Evidence (RWE), HEOR & Epidemiology CROs (HLAGAAAK), Clinical Data Management, Biostatistics & Statistical Programming CROs (HLAGAAAF), Pharmacovigilance, Risk Management & Medical Affairs CROs (HLAGAAAH), Medical Writing & Regulatory Submission Support CROs (HLAGAAAG), Specialty Therapeutic-Area CROs (e.g., oncology/rare disease) (HLAGAAAL)

Keywords

• Contract research services
• Clinical trial management
• Biostatistics data science
• Medical communications agency
• Market access HEOR

Headquarters

HQ city

Madrid

HQ country

Spain

HQ region

Europe

Offices6 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Technology or R&D, Operations, Marketing or Sales, Infrastructure

Revenue model

1. Contract Research Organization (CRO) Services: Evidenze provides full-value CRO services to pharmaceutical companies, biotechs, and MedTech companies. Services include study start-up, clinical operations, data management, biostatistics, medical writing, pharmacovigilance, QA audits, and regulatory affairs. Revenue is generated through project-based contracts and functional service provision (FSP) agreements with pharmaceutical sponsors.
2. Patient Support Programs: Home health services in clinical research and patient-oriented programs including call centers, home delivery of medical equipment, nursing services, patient clinical trial support, and medical content. Revenue generated through service contracts with healthcare providers and pharmaceutical sponsors.
3. Digital Health Solutions: Digital health consulting, eHealth solutions, mHealth apps, and technology platforms for healthcare transformation under the European Health Data Space framework. Revenue through public procurement of innovation (PPI), pre-commercial procurement (PCP), and consultancy contracts with pharmaceutical companies and public health systems.
4. Scientific Communication Services: Medical communication agency services including strategic scientific narratives, engagement programs, medical positioning, KOL engagement, and omnichannel communication for pharmaceutical and healthcare brands. Revenue generated through agency service contracts with pharma clients.
5. Market Access & HEOR: Health economics and outcomes research, market access strategy, value dossier development, cost-effectiveness models, and regulatory strategy services for pharmaceutical product launches. Revenue through consultancy engagements with pharma clients.

Go-to-market motion3 records

Distribution channels4 records

Marketing channels6 records

Core offering

Evidenze Group is a 'full-value' Contract Research Organization (CRO) that provides end-to-end clinical research services to pharmaceutical, biotech, and MedTech companies across 14+ European countries. Its core offerings span study start-up, clinical operations, electronic clinical trial tools (eCRF, ePRO, eConsent, eTMF, IWRS), data management, biostatistics and data science, medical writing, pharmacovigilance, and QA audits, supplemented by digital health solutions, patient support programs, scientific communications, and market access/HEOR services.

Product overview

Evidenze Group is a Full Value CRO (Contract Research Organization) operating as a platform-plus-modules architecture. The core Evidenze CRO platform provides end-to-end clinical research services supplemented by specialized modules including Study Start-up, Clinical Operations, Technological Tools (eCRF, ePRO, eConsent, eDiary, eTMF, eRND, IWRS), Data Management, Biostatistics & Data Science, Medical Writing, Pharmacovigilance, and QA Audits. The company also operates complementary service divisions: Digital Health (eHealth solutions under EHDS framework), Patient Support Programs (home health services), Scientific Communication (medical communication agency), and Market Access (HEOR services). The Biostatistics & Data Science Hub operates from Germany with over 60 experts supporting statistical programming, real-world evidence, and biomarker analysis. The portfolio enables pharmaceutical companies, biotechs, and MedTech companies to advance clinical development from early phases through product launch across 14+ European countries.

Differentiator

Problem solved

Functional benefit

Brands

• Evidenze Scientific Communication: Scientific communication agency combining science, creativity and strategy to help Health sector brands build real relationships with people. Services include 360° communication, medical training, scientific events, and scientific consulting.
• Evidenze Biostatistics & Data Science Hub

Products and services

• Evidenze CRO (Full Value Contract Research Organization) The flagship full-value CRO service providing end-to-end clinical research organization services for pharmaceutical companies, biotechs, and MedTech companies across all study phases, spanning 14+ European countries.
• Study Start-up Regulatory coordination and study initiation services for clinical trials, including preparation of protocols and patient information sheets, applications to health authorities and ethics committees, contract negotiation, site identification and selection, amendment management, and civil liability insurance processing.
• Clinical Operations Expert clinical research project management including site and investigator management, on-site and remote monitoring visits, secondary/telephone monitoring, recruitment follow-up, query resolution, investigational product accountability, biological sample management, SAE management, file maintenance, and project team resourcing, training, and coordination.
• Data Management Clinical data management services using state-of-the-art software including CRF design, eCRF development, query management, external data integration, and CDISC SDTM data sets to ensure data integrity and precise analysis in clinical studies.
• Biostatistics & Data Science Statistical programming and data science services across all study phases including SAS and R programming, CDISC SDTM/ADaM standards, early and late development statistics, biomarkers, RWE, R Shiny interactive dashboards, automated R Markdown/Quarto reporting pipelines, and HTA support — delivered by a 60+ expert hub in Essen, Germany.
• Medical Writing Scientific and medical writing services including protocol drafting, clinical study reports, scientific articles, congress publications, and product monographs across all study phases.
• Pharmacovigilance Drug safety monitoring and pharmacovigilance management services including safety database management, SAE evaluation, expedited reporting, DSUR/PSUR drafting, and safety agreement writing.
• QA Audits and Consultancy Quality assurance audits and GCP/GMP/GDP compliance consultancy including supplier audits, computer systems audits, and GCP training.
• Digital Health eHealth solutions and digital transformation consultancy under the European Health Data Space framework, including mHealth applications, healthcare process innovation, telemedicine support apps, and AI-based patient monitoring platforms for public administrations and pharma clients.
• Patient Support Programs Home health services in clinical research and patient-oriented programs including call centers, home delivery of medical equipment, nursing services, patient clinical trial compliance support, and medical content. Operational metrics include 6,000+ monthly calls, 1,000+ annual home visits, and 30,000+ patients helped.
• Scientific Communication Medical communication agency offering 360° services including strategic scientific narratives, engagement programs, KOL mapping and engagement, medical positioning, omnichannel communication, medical training, scientific events organization, scientific consulting, advisory boards, consensus building, and AI-powered chatbots for HCP and patient education. Team includes 52 scientists, 24 creatives, 8 developers, and 22 AV & Events staff.
• Market Access and HEOR Market access strategy and Health Economics and Outcomes Research (HEOR) services including value dossier development, economic evaluations, cost-effectiveness models, stakeholder mapping, real-world evidence generation, and regulatory strategy support for pharmaceutical product launches across EU HTA regulation and AMNOG processes.

Quantifiable outcome

• Over 100 product launches supported in key therapeutic areas
• +7 more outcomes

Named customers8 records

Segments5 records

Ideal customer profiles4 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability8 records

Feature15 records

Partnerships

Four partnerships are on record, tiered strategic and core.

• TelefonicastrategicTechnology or Integration · 1 June 2026Telefonica announced a contract to build a healthcare data space for Evidenze, aimed at advancing clinical research and accelerating healthcare technology development. The partnership seeks to enable reuse of health data for research and advanced analytics while creating a collaborative environment for stakeholders across Spain's healthcare sector.
• CatSalut (Catalan Health Service)strategicStrategic or Co-development PartnerCatSalut coordinated innovative public procurement (CPI) projects including the FEEDING CARE project led by Parc Taulí Hospital in Sabadell. Evidenze serves as the solution provider for healthcare innovation projects.
• Parc Taulí Hospital (Sabadell)coreImplementation/ SI/ Consulting PartnerParc Taulí Hospital led the tender for the FEEDING CARE CPI project for neonatology patient nutrition management. Evidenze developed the innovative solution.
• Murcian Health ServicestrategicImplementation/ SI/ Consulting PartnerMurcian Health Service partnered with Evidenze on the Patient Circle project for e-health services enabling patient-professional communication through collaborative environments.

Scale indicators15 records

Recent moves6 records

Expansion highlights7 records

Broad incumbents

• IQVIA: The world's largest CRO and life sciences services firm, spanning clinical operations, real-world evidence, biostatistics, and technology platforms across all major geographies. Comparable to Evidenze across nearly every service line, but at vastly greater scale and global reach.
• ICON plc: Top-3 global CRO providing clinical research, biostatistics, laboratory, and consulting services post-PRA Health Sciences integration. Directly competes with Evidenze in European biotech/small-mid pharma trial outsourcing and biostatistics, but with much greater global footprint and headcount.
• Fortrea (Labcorp Drug Development spin-off): Post-2023 spin-off from Labcorp, Fortrea is a full-service clinical CRO offering Phase I–IV trial management, biostatistics, and consulting. Closely comparable to Evidenze as a mid-to-large clinical CRO serving pharma/biotech sponsors with similar service breadth.
• Parexel International: Global CRO with strong biotech/small-pharma franchise (especially post-Pamplona), biostatistics, and clinical operations across multiple therapeutic areas. Comparable to Evidenze in target customer segments and breadth of services, with greater geographic coverage.
• Charles River Laboratories: Large CRO/early-stage research services firm with deep European presence, particularly in Discovery/Safety Assessment and Biopharma Services. Adjacent to Evidenze in preclinical/early-phase services and biostatistics outsourcing.

Direct peers

• Medpace: Mid-sized, profitable full-service CRO with strong biotech/small-mid pharma focus. Highly comparable target customer base, therapeutic-area specialization approach, and full-service operating model to Evidenze's 'Full Value CRO' positioning.
• Worldwide Clinical Trials: Mid-sized global CRO specializing in complex clinical trials in therapeutic areas including neuroscience, rare diseases, and immunology — directly overlapping with Evidenze's named specialty therapeutic areas. Comparable mid-market scale and customer base.
• TFS International: European-headquartered mid-sized CRO with similar biotech/small-mid pharma focus and FSP/outsourcing service models. Closely comparable in size, European geographic focus, and customer segment to Evidenze.
• SGS Life Sciences: Global mid-sized CRO with strong European footprint offering clinical research, biostatistics, pharmacovigilance, and laboratory services — directly comparable to Evidenze in scope, scale, and customer base.

Others

• Veeva Systems: Leading life-sciences cloud software provider whose CDB/CTMS/eTMF/Safety platforms overlap with several of Evidenze's electronic clinical trial tools (eCRF, eTMF, IWRS). Not a direct CRO competitor but a key enabling technology peer and strategic partner/competitor in CRO technology.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks5 records

Key highlights7 records

Customer concentration

Compliance6 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles3 records

Subsidiaries2 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A1 record

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Evidenze Group